메뉴 건너뛰기




Volumn 26, Issue 24, 2008, Pages 3078-3085

Traitors of the immune system-Enhancing antibodies in HIV infection: Their possible implication in HIV vaccine development

Author keywords

Antibodies; C ADE; Complement; Enhancement; Enhancing; Fc receptor; HIV; Vaccine

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; RESPIRATORY SYNCYTIAL VIRUS VACCINE; VIRUS ANTIBODY;

EID: 44649191357     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.12.028     Document Type: Article
Times cited : (39)

References (56)
  • 1
    • 1542471132 scopus 로고    scopus 로고
    • AIDS vaccine fails in Thai trial
    • McCarthy M. AIDS vaccine fails in Thai trial. Lancet 362 9397 (2003) 1728
    • (2003) Lancet , vol.362 , Issue.9397 , pp. 1728
    • McCarthy, M.1
  • 2
    • 0037362934 scopus 로고    scopus 로고
    • HIV vaccine fails in phase 3 trial
    • McCarthy M. HIV vaccine fails in phase 3 trial. Lancet 361 9359 (2003) 755-756
    • (2003) Lancet , vol.361 , Issue.9359 , pp. 755-756
    • McCarthy, M.1
  • 3
    • 35148818748 scopus 로고    scopus 로고
    • AIDS research. Promising AIDS vaccine's failure leaves field reeling
    • Cohen J. AIDS research. Promising AIDS vaccine's failure leaves field reeling. Science 318 5847 (2007) 28-29
    • (2007) Science , vol.318 , Issue.5847 , pp. 28-29
    • Cohen, J.1
  • 4
    • 4644249733 scopus 로고    scopus 로고
    • Predicting the impact of a nonsterilizing vaccine against human immunodeficiency virus
    • Davenport M.P., Ribeiro R.M., Chao D.L., and Perelson A.S. Predicting the impact of a nonsterilizing vaccine against human immunodeficiency virus. J Virol 78 20 (2004) 11340-11351
    • (2004) J Virol , vol.78 , Issue.20 , pp. 11340-11351
    • Davenport, M.P.1    Ribeiro, R.M.2    Chao, D.L.3    Perelson, A.S.4
  • 5
    • 4344693298 scopus 로고    scopus 로고
    • Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160
    • Lee D., Graham B.S., Chiu Y.L., Gilbert P.B., McElrath M.J., Belshe R.B., et al. Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160. J Infect Dis 190 5 (2004) 903-907
    • (2004) J Infect Dis , vol.190 , Issue.5 , pp. 903-907
    • Lee, D.1    Graham, B.S.2    Chiu, Y.L.3    Gilbert, P.B.4    McElrath, M.J.5    Belshe, R.B.6
  • 6
    • 13944254982 scopus 로고    scopus 로고
    • Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection
    • Flynn N.M., Forthal D.N., Harro C.D., Judson F.N., Mayer K.H., and Para M.F. Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J Infect Dis 191 5 (2005) 654-665
    • (2005) J Infect Dis , vol.191 , Issue.5 , pp. 654-665
    • Flynn, N.M.1    Forthal, D.N.2    Harro, C.D.3    Judson, F.N.4    Mayer, K.H.5    Para, M.F.6
  • 7
    • 0022511286 scopus 로고
    • Antibody-dependent enhancement of viral infectivity
    • Porterfield J.S. Antibody-dependent enhancement of viral infectivity. Adv Virus Res 31 (1986) 335-355
    • (1986) Adv Virus Res , vol.31 , pp. 335-355
    • Porterfield, J.S.1
  • 8
    • 85013269265 scopus 로고    scopus 로고
    • Enhancing antibodies in HIV infection
    • Fust G. Enhancing antibodies in HIV infection. Parasitology 115 Suppl (1997) S127-S140
    • (1997) Parasitology , vol.115 , Issue.SUPPL
    • Fust, G.1
  • 9
    • 0037257790 scopus 로고    scopus 로고
    • Antibody-dependent enhancement of virus infection and disease
    • Tirado S.M., and Yoon K.J. Antibody-dependent enhancement of virus infection and disease. Viral Immunol 16 1 (2003) 69-86
    • (2003) Viral Immunol , vol.16 , Issue.1 , pp. 69-86
    • Tirado, S.M.1    Yoon, K.J.2
  • 10
    • 0018580825 scopus 로고
    • In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody
    • Halstead S.B. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis 140 4 (1979) 527-533
    • (1979) J Infect Dis , vol.140 , Issue.4 , pp. 527-533
    • Halstead, S.B.1
  • 11
    • 0014775305 scopus 로고
    • Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered
    • Halstead S.B., Nimmannitya S., and Cohen S.N. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med 42 5 (1970) 311-328
    • (1970) Yale J Biol Med , vol.42 , Issue.5 , pp. 311-328
    • Halstead, S.B.1    Nimmannitya, S.2    Cohen, S.N.3
  • 12
    • 0023818748 scopus 로고
    • Pathogenesis of dengue: challenges to molecular biology
    • Halstead S.B. Pathogenesis of dengue: challenges to molecular biology. Science 239 4839 (1988) 476-481
    • (1988) Science , vol.239 , Issue.4839 , pp. 476-481
    • Halstead, S.B.1
  • 14
    • 0024565393 scopus 로고
    • Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever
    • Kliks S.C., Nisalak A., Brandt W.E., Wahl L., and Burke D.S. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 40 4 (1989) 444-451
    • (1989) Am J Trop Med Hyg , vol.40 , Issue.4 , pp. 444-451
    • Kliks, S.C.1    Nisalak, A.2    Brandt, W.E.3    Wahl, L.4    Burke, D.S.5
  • 15
    • 33846079822 scopus 로고    scopus 로고
    • Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS)
    • Pang T., Cardosa M.J., and Guzman M.G. Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol 85 1 (2007) 43-45
    • (2007) Immunol Cell Biol , vol.85 , Issue.1 , pp. 43-45
    • Pang, T.1    Cardosa, M.J.2    Guzman, M.G.3
  • 16
    • 0022450456 scopus 로고
    • A new mechanism for the neutralization of enveloped viruses by antiviral antibody
    • Gollins S.W., and Porterfield J.S. A new mechanism for the neutralization of enveloped viruses by antiviral antibody. Nature 321 6067 (1986) 244-246
    • (1986) Nature , vol.321 , Issue.6067 , pp. 244-246
    • Gollins, S.W.1    Porterfield, J.S.2
  • 17
    • 0033970916 scopus 로고    scopus 로고
    • Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity
    • Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., Suntayakorn S., et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181 1 (2000) 2-9
    • (2000) J Infect Dis , vol.181 , Issue.1 , pp. 2-9
    • Vaughn, D.W.1    Green, S.2    Kalayanarooj, S.3    Innis, B.L.4    Nimmannitya, S.5    Suntayakorn, S.6
  • 18
    • 1642415963 scopus 로고    scopus 로고
    • Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand
    • Endy T.P., Nisalak A., Chunsuttitwat S., Vaughn D.W., Green S., Ennis F.A., et al. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis 189 6 (2004) 990-1000
    • (2004) J Infect Dis , vol.189 , Issue.6 , pp. 990-1000
    • Endy, T.P.1    Nisalak, A.2    Chunsuttitwat, S.3    Vaughn, D.W.4    Green, S.5    Ennis, F.A.6
  • 19
    • 0020574705 scopus 로고
    • Complement receptor mediates enhanced flavivirus replication in macrophages
    • Cardosa M.J., Porterfield J.S., and Gordon S. Complement receptor mediates enhanced flavivirus replication in macrophages. J Exp Med 158 1 (1983) 258-263
    • (1983) J Exp Med , vol.158 , Issue.1 , pp. 258-263
    • Cardosa, M.J.1    Porterfield, J.S.2    Gordon, S.3
  • 20
    • 0014844884 scopus 로고
    • Influence of immunological factors in respiratory syncytial virus disease
    • Chanock R.M., Kapikian A.Z., Mills J., Kim H.W., and Parrott R.H. Influence of immunological factors in respiratory syncytial virus disease. Arch Environ Health 21 3 (1970) 347-355
    • (1970) Arch Environ Health , vol.21 , Issue.3 , pp. 347-355
    • Chanock, R.M.1    Kapikian, A.Z.2    Mills, J.3    Kim, H.W.4    Parrott, R.H.5
  • 21
    • 0037446912 scopus 로고    scopus 로고
    • Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the Bonnet monkey model
    • Ponnuraj E.M., Springer J., Hayward A.R., Wilson H., and Simoes E.A. Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the Bonnet monkey model. J Infect Dis 187 8 (2003) 1257-1263
    • (2003) J Infect Dis , vol.187 , Issue.8 , pp. 1257-1263
    • Ponnuraj, E.M.1    Springer, J.2    Hayward, A.R.3    Wilson, H.4    Simoes, E.A.5
  • 22
    • 0038467640 scopus 로고    scopus 로고
    • Antibody-dependent enhancement of Ebola virus infection
    • Takada A., Feldmann H., Ksiazek T.G., and Kawaoka Y. Antibody-dependent enhancement of Ebola virus infection. J Virol 77 13 (2003) 7539-7544
    • (2003) J Virol , vol.77 , Issue.13 , pp. 7539-7544
    • Takada, A.1    Feldmann, H.2    Ksiazek, T.G.3    Kawaoka, Y.4
  • 23
    • 33748659233 scopus 로고    scopus 로고
    • Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response
    • Iankov I.D., Pandey M., Harvey M., Griesmann G.E., Federspiel M.J., and Russell S.J. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. J Virol 80 17 (2006) 8530-8540
    • (2006) J Virol , vol.80 , Issue.17 , pp. 8530-8540
    • Iankov, I.D.1    Pandey, M.2    Harvey, M.3    Griesmann, G.E.4    Federspiel, M.J.5    Russell, S.J.6
  • 24
    • 35548935103 scopus 로고    scopus 로고
    • Immunisation strategies for the management of severe acute respiratory syndrome (SARS)
    • Pletz M.W., Dickgreber N., Hagen L., Golpon H., Zabel P., Bauer T.T., et al. Immunisation strategies for the management of severe acute respiratory syndrome (SARS). Pneumologie 61 10 (2007) 663-667
    • (2007) Pneumologie , vol.61 , Issue.10 , pp. 663-667
    • Pletz, M.W.1    Dickgreber, N.2    Hagen, L.3    Golpon, H.4    Zabel, P.5    Bauer, T.T.6
  • 25
    • 0023567926 scopus 로고
    • A human immunodeficiency virus type 1 (HIV-1) infection-enhancing factor in seropositive sera
    • Robinson Jr. W.E., Montefiori D.C., and Mitchell W.M. A human immunodeficiency virus type 1 (HIV-1) infection-enhancing factor in seropositive sera. Biochem Biophys Res Commun 149 2 (1987) 693-699
    • (1987) Biochem Biophys Res Commun , vol.149 , Issue.2 , pp. 693-699
    • Robinson Jr., W.E.1    Montefiori, D.C.2    Mitchell, W.M.3
  • 26
    • 0023935853 scopus 로고
    • Antibody-dependent enhancement of human immunodeficiency virus type 1 infection
    • Robinson Jr. W.E., Montefiori D.C., and Mitchell W.M. Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet 1 8589 (1988) 790-794
    • (1988) Lancet , vol.1 , Issue.8589 , pp. 790-794
    • Robinson Jr., W.E.1    Montefiori, D.C.2    Mitchell, W.M.3
  • 27
    • 0026051133 scopus 로고
    • Antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human, Epstein-Barr virus-transformed B-lymphocytic cell line
    • Gras G.S., and Dormont D. Antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human, Epstein-Barr virus-transformed B-lymphocytic cell line. J Virol 65 1 (1991) 541-545
    • (1991) J Virol , vol.65 , Issue.1 , pp. 541-545
    • Gras, G.S.1    Dormont, D.2
  • 28
    • 0024564268 scopus 로고
    • Complement-mediated, antibody-dependent enhancement of HIV-1 infection in vitro is characterized by increased protein and RNA syntheses and infectious virus release
    • Robinson Jr. W.E., Montefiori D.C., Gillespie D.H., and Mitchell W.M. Complement-mediated, antibody-dependent enhancement of HIV-1 infection in vitro is characterized by increased protein and RNA syntheses and infectious virus release. J Acquir Immune Defic Syndr 2 1 (1989) 33-42
    • (1989) J Acquir Immune Defic Syndr , vol.2 , Issue.1 , pp. 33-42
    • Robinson Jr., W.E.1    Montefiori, D.C.2    Gillespie, D.H.3    Mitchell, W.M.4
  • 29
    • 0023803544 scopus 로고
    • Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry
    • Takeda A., Tuazon C.U., and Ennis F.A. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 242 4878 (1988) 580-583
    • (1988) Science , vol.242 , Issue.4878 , pp. 580-583
    • Takeda, A.1    Tuazon, C.U.2    Ennis, F.A.3
  • 30
    • 0024390828 scopus 로고
    • The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells
    • Homsy J., Meyer M., Tateno M., Clarkson S., and Levy J.A. The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science 244 4910 (1989) 1357-1360
    • (1989) Science , vol.244 , Issue.4910 , pp. 1357-1360
    • Homsy, J.1    Meyer, M.2    Tateno, M.3    Clarkson, S.4    Levy, J.A.5
  • 31
    • 0025212678 scopus 로고
    • Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals
    • Homsy J., Meyer M., and Levy J.A. Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals. J Virol 64 4 (1990) 1437-1440
    • (1990) J Virol , vol.64 , Issue.4 , pp. 1437-1440
    • Homsy, J.1    Meyer, M.2    Levy, J.A.3
  • 32
    • 34548496893 scopus 로고    scopus 로고
    • Fc receptor but not complement binding is important in antibody protection against HIV
    • Hessell A.J., Hangartner L., Hunter M., Havenith C.E., Beurskens F.J., Bakker J.M., et al. Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449 7158 (2007) 101-104
    • (2007) Nature , vol.449 , Issue.7158 , pp. 101-104
    • Hessell, A.J.1    Hangartner, L.2    Hunter, M.3    Havenith, C.E.4    Beurskens, F.J.5    Bakker, J.M.6
  • 33
    • 0025253117 scopus 로고
    • Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro
    • Robinson Jr. W.E., Kawamura T., Gorny M.K., Lake D., Xu J.Y., Matsumoto Y., et al. Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro. Proc Natl Acad Sci USA 87 8 (1990) 3185-3189
    • (1990) Proc Natl Acad Sci USA , vol.87 , Issue.8 , pp. 3185-3189
    • Robinson Jr., W.E.1    Kawamura, T.2    Gorny, M.K.3    Lake, D.4    Xu, J.Y.5    Matsumoto, Y.6
  • 34
    • 0025131885 scopus 로고
    • Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro
    • Robinson Jr. W.E., Kawamura T., Lake D., Masuho Y., Mitchell W.M., and Hersh E.M. Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro. J Virol 64 11 (1990) 5301-5305
    • (1990) J Virol , vol.64 , Issue.11 , pp. 5301-5305
    • Robinson Jr., W.E.1    Kawamura, T.2    Lake, D.3    Masuho, Y.4    Mitchell, W.M.5    Hersh, E.M.6
  • 35
    • 0029044657 scopus 로고
    • Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1
    • Prohaszka Z., Hidvegi T., Ujhelyi E., Stoiber H., Dierich M.P., Susal C., et al. Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1. Immunology 85 2 (1995) 184-189
    • (1995) Immunology , vol.85 , Issue.2 , pp. 184-189
    • Prohaszka, Z.1    Hidvegi, T.2    Ujhelyi, E.3    Stoiber, H.4    Dierich, M.P.5    Susal, C.6
  • 36
    • 0025861673 scopus 로고
    • Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro
    • Robinson Jr. W.E., Gorny M.K., Xu J.Y., Mitchell W.M., and Zolla-Pazner S. Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro. J Virol 65 8 (1991) 4169-4176
    • (1991) J Virol , vol.65 , Issue.8 , pp. 4169-4176
    • Robinson Jr., W.E.1    Gorny, M.K.2    Xu, J.Y.3    Mitchell, W.M.4    Zolla-Pazner, S.5
  • 37
    • 0032556957 scopus 로고    scopus 로고
    • Inactivation of a common epitope responsible for the induction of antibody-dependent enhancement of HIV
    • Mitchell W.M., Ding L., and Gabriel J. Inactivation of a common epitope responsible for the induction of antibody-dependent enhancement of HIV. Aids 12 2 (1998) 147-156
    • (1998) Aids , vol.12 , Issue.2 , pp. 147-156
    • Mitchell, W.M.1    Ding, L.2    Gabriel, J.3
  • 38
    • 33750952525 scopus 로고    scopus 로고
    • Mechanism for complement-mediated, antibody-dependent enhancement of human immunodeficiency virus type 1 infection in MT2 cells is enhanced entry through CD4, CD21, and CXCR4 chemokine receptors
    • Robinson W.E. Mechanism for complement-mediated, antibody-dependent enhancement of human immunodeficiency virus type 1 infection in MT2 cells is enhanced entry through CD4, CD21, and CXCR4 chemokine receptors. Viral Immunol 19 3 (2006) 434-447
    • (2006) Viral Immunol , vol.19 , Issue.3 , pp. 434-447
    • Robinson, W.E.1
  • 39
    • 8244253673 scopus 로고    scopus 로고
    • Two parallel routes of the complement-mediated antibody-dependent enhancement of HIV-1 infection
    • Prohaszka Z., Nemes J., Hidvegi T., Toth F.D., Kerekes K., Erdei A., et al. Two parallel routes of the complement-mediated antibody-dependent enhancement of HIV-1 infection. Aids 11 8 (1997) 949-958
    • (1997) Aids , vol.11 , Issue.8 , pp. 949-958
    • Prohaszka, Z.1    Nemes, J.2    Hidvegi, T.3    Toth, F.D.4    Kerekes, K.5    Erdei, A.6
  • 42
    • 0028861341 scopus 로고
    • Antibodies to the putative SIV infection-enhancing domain diminish beneficial effects of an SIV gp160 vaccine in rhesus macaques
    • Mitchell W.M., Torres J., Johnson P.R., Hirsch V., Yilma T., Gardner M.B., et al. Antibodies to the putative SIV infection-enhancing domain diminish beneficial effects of an SIV gp160 vaccine in rhesus macaques. Aids 9 1 (1995) 27-34
    • (1995) Aids , vol.9 , Issue.1 , pp. 27-34
    • Mitchell, W.M.1    Torres, J.2    Johnson, P.R.3    Hirsch, V.4    Yilma, T.5    Gardner, M.B.6
  • 43
    • 0036263196 scopus 로고    scopus 로고
    • Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients
    • Subbramanian R.A., Xu J., Toma E., Morisset R., Cohen E.A., Menezes J., et al. Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients. J Clin Microbiol 40 6 (2002) 2141-2146
    • (2002) J Clin Microbiol , vol.40 , Issue.6 , pp. 2141-2146
    • Subbramanian, R.A.1    Xu, J.2    Toma, E.3    Morisset, R.4    Cohen, E.A.5    Menezes, J.6
  • 44
    • 0025796729 scopus 로고
    • Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection
    • Toth F.D., Szabo B., Ujhelyi E., Paloczi K., Horvath A., Fust G., et al. Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection. Aids 5 3 (1991) 263-268
    • (1991) Aids , vol.5 , Issue.3 , pp. 263-268
    • Toth, F.D.1    Szabo, B.2    Ujhelyi, E.3    Paloczi, K.4    Horvath, A.5    Fust, G.6
  • 45
    • 2442764677 scopus 로고    scopus 로고
    • Strong correlation between the complement-mediated antibody-dependent enhancement of HIV-1 infection and plasma viral load
    • Szabo J., Prohaszka Z., Toth F.D., Gyuris A., Segesdi J., Banhegyi D., et al. Strong correlation between the complement-mediated antibody-dependent enhancement of HIV-1 infection and plasma viral load. Aids 13 14 (1999) 1841-1849
    • (1999) Aids , vol.13 , Issue.14 , pp. 1841-1849
    • Szabo, J.1    Prohaszka, Z.2    Toth, F.D.3    Gyuris, A.4    Segesdi, J.5    Banhegyi, D.6
  • 46
    • 0028269618 scopus 로고
    • Neutralizing and enhancing antibodies measured in complement-restored serum samples from HIV-1-infected individuals correlate with immunosuppression and disease
    • Fust G., Toth F.D., Kiss J., Ujhelyi E., Nagy I., and Banhegyi D. Neutralizing and enhancing antibodies measured in complement-restored serum samples from HIV-1-infected individuals correlate with immunosuppression and disease. Aids 8 5 (1994) 603-609
    • (1994) Aids , vol.8 , Issue.5 , pp. 603-609
    • Fust, G.1    Toth, F.D.2    Kiss, J.3    Ujhelyi, E.4    Nagy, I.5    Banhegyi, D.6
  • 47
    • 0142042944 scopus 로고    scopus 로고
    • Significant decrease of the enhancement/neutralization index in HIV patients during highly active antiretroviral therapy (HAART)
    • Banhegyi D., Bacsi A., Toth F.D., Prohaszka Z., Horvath A., Beck Z., et al. Significant decrease of the enhancement/neutralization index in HIV patients during highly active antiretroviral therapy (HAART). Immunol Lett 89 1 (2003) 25-30
    • (2003) Immunol Lett , vol.89 , Issue.1 , pp. 25-30
    • Banhegyi, D.1    Bacsi, A.2    Toth, F.D.3    Prohaszka, Z.4    Horvath, A.5    Beck, Z.6
  • 48
    • 0025804179 scopus 로고
    • Absence of a clinical correlation for complement-mediated, infection-enhancing antibodies in plasma or sera from HIV-1-infected individuals. Multicenter AIDS Cohort Study Group
    • Montefiori D.C., Lefkowitz Jr. L.B., Keller R.E., Holmberg V., Sandstrom E., and Phair J.P. Absence of a clinical correlation for complement-mediated, infection-enhancing antibodies in plasma or sera from HIV-1-infected individuals. Multicenter AIDS Cohort Study Group. Aids 5 5 (1991) 513-517
    • (1991) Aids , vol.5 , Issue.5 , pp. 513-517
    • Montefiori, D.C.1    Lefkowitz Jr., L.B.2    Keller, R.E.3    Holmberg, V.4    Sandstrom, E.5    Phair, J.P.6
  • 49
    • 0030057730 scopus 로고    scopus 로고
    • Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors
    • Montefiori D.C., Pantaleo G., Fink L.M., Zhou J.T., Zhou J.Y., Bilska M., et al. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. J Infect Dis 173 1 (1996) 60-67
    • (1996) J Infect Dis , vol.173 , Issue.1 , pp. 60-67
    • Montefiori, D.C.1    Pantaleo, G.2    Fink, L.M.3    Zhou, J.T.4    Zhou, J.Y.5    Bilska, M.6
  • 50
    • 0034385414 scopus 로고    scopus 로고
    • Macaque immunization with virions purified from a primary isolate of the human immunodeficiency virus type 1 induced enhancement antibodies
    • discussion 85-7
    • Verrier F., Moog C., Barre-Sinoussi F., Van der Ryst E., Spenlehauer C., and Girard M. Macaque immunization with virions purified from a primary isolate of the human immunodeficiency virus type 1 induced enhancement antibodies. Bull Acad Natl Med 184 1 (2000) 67-84 discussion 85-7
    • (2000) Bull Acad Natl Med , vol.184 , Issue.1 , pp. 67-84
    • Verrier, F.1    Moog, C.2    Barre-Sinoussi, F.3    Van der Ryst, E.4    Spenlehauer, C.5    Girard, M.6
  • 51
    • 2442689092 scopus 로고    scopus 로고
    • Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies
    • Haigwood N.L., Montefiori D.C., Sutton W.F., McClure J., Watson A.J., Voss G., et al. Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies. J Virol 78 11 (2004) 5983-5995
    • (2004) J Virol , vol.78 , Issue.11 , pp. 5983-5995
    • Haigwood, N.L.1    Montefiori, D.C.2    Sutton, W.F.3    McClure, J.4    Watson, A.J.5    Voss, G.6
  • 52
    • 4444316121 scopus 로고    scopus 로고
    • Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein
    • Staprans S.I., Barry A.P., Silvestri G., Safrit J.T., Kozyr N., Sumpter B., et al. Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein. Proc Natl Acad Sci USA 101 35 (2004) 13026-13031
    • (2004) Proc Natl Acad Sci USA , vol.101 , Issue.35 , pp. 13026-13031
    • Staprans, S.I.1    Barry, A.P.2    Silvestri, G.3    Safrit, J.T.4    Kozyr, N.5    Sumpter, B.6
  • 53
    • 0028670689 scopus 로고
    • Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network
    • Keefer M.C., Graham B.S., Belshe R.B., Schwartz D., Corey L., Bolognesi D.P., et al. Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network. AIDS Res Hum Retroviruses 10 12 (1994) 1713-1723
    • (1994) AIDS Res Hum Retroviruses , vol.10 , Issue.12 , pp. 1713-1723
    • Keefer, M.C.1    Graham, B.S.2    Belshe, R.B.3    Schwartz, D.4    Corey, L.5    Bolognesi, D.P.6
  • 54
    • 0026019644 scopus 로고
    • The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network
    • Dolin R., Graham B.S., Greenberg S.B., Tacket C.O., Belshe R.B., Midthun K., et al. The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. Ann Intern Med 114 2 (1991) 119-127
    • (1991) Ann Intern Med , vol.114 , Issue.2 , pp. 119-127
    • Dolin, R.1    Graham, B.S.2    Greenberg, S.B.3    Tacket, C.O.4    Belshe, R.B.5    Midthun, K.6
  • 55
    • 13944250922 scopus 로고    scopus 로고
    • Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial
    • Gilbert P.B., Peterson M.L., Follmann D., Hudgens M.G., Francis D.P., Gurwith M., et al. Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial. J Infect Dis 191 5 (2005) 666-677
    • (2005) J Infect Dis , vol.191 , Issue.5 , pp. 666-677
    • Gilbert, P.B.1    Peterson, M.L.2    Follmann, D.3    Hudgens, M.G.4    Francis, D.P.5    Gurwith, M.6
  • 56
    • 13944262072 scopus 로고    scopus 로고
    • Lessons from failure - preparing for future HIV-1 vaccine efficacy trials
    • Graham B.S., and Mascola J.R. Lessons from failure - preparing for future HIV-1 vaccine efficacy trials. J Infect Dis 191 5 (2005) 647-649
    • (2005) J Infect Dis , vol.191 , Issue.5 , pp. 647-649
    • Graham, B.S.1    Mascola, J.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.